F-1/A: Empro Group Inc. Files for $5 Million IPO, Aiming for Nasdaq Listing

Empro Group Inc., a Malaysian beauty and healthcare products company, seeks to raise $5 million through an initial public offering on the Nasdaq Capital Market.

Summary

• Empro Group Inc., a Cayman Islands-based holding company with operations in Malaysia, has filed an amendment to its F-1 registration statement for an initial public offering.
• The company plans to offer 1,250,000 ordinary shares with an expected price range of $4.00 to $4.50 per share, aiming to raise $5 million in gross proceeds.
• Empro Group's primary operating subsidiary, EMP Solution Sdn. Bhd., distributes healthcare and beauty products throughout the ASEAN region and Europe.
• The company's flagship products include triangular eyebrow pencils and surgical face masks featuring Aerofit technology.
• For the fiscal year ended December 31, 2024, Empro Group reported total revenue of $5.48 million and a net profit of $0.75 million.
• The company intends to use the IPO proceeds for working capital, market penetration, operating expenses, and transaction expenses.
• Yeoh Chee Wei, the founder, CEO, and Chairman, will retain approximately 64.7% ownership post-IPO, making Empro Group a controlled company under Nasdaq rules.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth in the cosmetics and skincare segment and a return to profitability. However, it also acknowledges risks related to competition, market volatility, and reliance on third-party suppliers, resulting in a moderate sentiment score.

Positives

• The company has a rich brand history spanning over 19 years.
• Empro Group has a track record of delivering safe, efficacious, and innovative beauty and healthcare products.
• The company has established strong relationships with partners, regulators, and government agencies.
• The company boasts a robust and experienced management team.
• The company's revenue diversification following the introduction of new products in the beauty segment enhances its financial resilience.
• The company's marketing strategy is adaptable, designed to evolve in response to local market dynamics.

Negatives

• The company operates in a dynamic healthcare and beauty industry and has a limited operating history.
• The healthcare industry and the beauty industry are highly competitive.
• The company's total revenue, and the revenue generated by its healthcare business segment, decreased considerably during the 2023 fiscal year due to a marked reduction in COVID-19 cases.
• The company relies on third-party e-commerce platforms to sell its products online.
• The company relies on a limited number of ODM/OEM and packaging supply partners to produce its products.
• The company may be subject to export and import control laws and regulations that could impair its ability to compete in international markets or subject it to liability if it violates such laws and regulations.

Risks

• The company's historical results may not be indicative of future performance.
• The company's success depends on the continued popularity of its products and its ability to respond to changes in industry trends.
• New product introductions may not be as successful as anticipated.
• The company may be unable to manage its growth effectively or efficiently.
• The company may not be able to maintain profitability in the future.
• The sale of counterfeit products may affect the company's reputation and profitability.
• The company's operating results could be materially harmed if it is unable to accurately forecast consumer demand for its products or adequately manage its inventory.
• The market price of the company's ordinary shares may be volatile or may decline regardless of its operating performance.
• The company is controlled by a single shareholder, whose interest in its business may be different than yours.
• The company is a controlled company within the meaning of The Nasdaq Capital Market or, Nasdaq, listing rules.

Future Outlook

Empro Group intends to expand its product offerings, enter new markets within ASEAN and Europe, and invest in new technologies to strengthen brand loyalty and develop its business.

Management Comments

• Under the leadership of our founder, Mr. Yeoh, our company has steadily and successfully transcended its humble origins in the beauty industry during an operating history that spans nearly two decades.
• We believe that this multifaceted strategic synergy will remain pivotal in securing sustained success and a prominent industry position as we navigate into the future.

Industry Context

The beauty and healthcare industries are highly competitive, with Empro Group facing rivalry from both national and international entities. The company's success depends on its ability to adapt to changing consumer preferences and industry trends.

Comparison to Industry Standards

• The beauty market is experiencing significant growth both globally and in the Asia-Pacific region (APAC), excluding China, as detailed in McKinseys The State of Fashion: Beauty 2023 report.
• Globally, the industry is projected to generate retail sales of $460 billion in 2023, with expectations to reach $580 billion by 2027, demonstrating a compound annual growth rate (CAGR) of approximately 6%.
• In the APAC region, excluding China, the market is notably robust, expected to achieve retail sales of $118 billion in 2023, accounting for around 26% of the global market.
• This market is anticipated to outpace the global growth rate, with a CAGR of approximately 7%, reaching $151 billion by 2027.
• In Malaysia, the PPE market is valued at $481 million in 2023 and is anticipated to grow at a CAGR of 7% from 2023 to 2029, reaching $736 million.

Related Party Transactions

• EMP Solution entered into an Exclusive Sole Distribution agreement with Jingga Anggun Sdn Bhd, where the sole director is the son of Mr. Yeoh, and Chin Gan Keat is the Chief Operating Officer.
• EMP Solution has an arrangement with Mosfac Sdn Bhd, where Mr. Yeoh is a 50% shareholder and a director.
• EMP Solution has outstanding receivables from Mimo Motor Sdn Bhd, where Mr. Yeoh is the sole shareholder and a director.
• EMP Solution has outstanding payables to Brand Multi Plus Sdn Bhd, where the sole director and shareholder is the son of Mr. Yeoh.

Stakeholder Impact

• Shareholders will experience immediate and substantial dilution in the net tangible book value of Ordinary Shares purchased.
• The company's performance is dependent on the performance of the economy and consumer spending patterns in the countries in which it operates.
• The company's financial performance is subject to political, economic, social, regulatory and other developments in the countries in which it operates.

Next Steps

• The company aims to list its ordinary shares on the Nasdaq Capital Market.
• The company intends to expand its product offerings and develop new products.
• The company intends to expand into new markets and territories within ASEAN and Europe.
• The company intends to invest in new technologies.

Key Dates

Keywords

IPO, Empro Group, beauty products, healthcare products, Nasdaq, initial public offering, eyebrow pencils, face masks, skincare, ASEAN